Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i> BRAF <sup>V600E</sup> </i> -Mutated Anaplastic Thyroid CarcinomaJennifer Wang, Maria E. Cabanillas, William H. Morrison et al.|Thyroid|2019Cited by 229
Phase 2 study of pembrolizumab in patients with advanced rare cancersAung Naing, Mouhammed Amir Habra, Funda Meric‐Bernstam et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 130
Initial Management of <i>BRAF </i>V600E-Variant Anaplastic Thyroid CancerSarah Hamidi, Maria E. Cabanillas, Ramona Dadu et al.|JAMA Oncology|2024Cited by 35
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive TumorsLuana Guimarães de Sousa, Renata Ferrarotto|Clinical Cancer Research|2023Cited by 28
Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid CancerMaria E. Cabanillas, Naifa L. Busaidy, G. Brandon Gunn et al.|Thyroid|2025Cited by 8